Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 13091-13100 Newer>

The Motley Fool March 17, 2006 Nathan Parmelee	The Power of Assists Dividends aren't flashy and quite often they're ignored altogether. However, over years, dividends allow investors to rack up larger gains.
The Motley Fool March 17, 2006 Nathan Parmelee	SoftBank Pays Up for Vodafone Japan Vodafone will receive $11.95 billion in cash, with the remainder of the purchase price in preferred shares and debt. Happily, U.S. ADR holders should expect a dividend of $1.75 per ADR.
The Motley Fool March 17, 2006 Alyce Lomax	H&R Chopping Block H&R Block's shares have crumbled to a 52-week low this week. The company is standing by its financial guidance for the coming year, though it's already admitting to slow customer traffic. Investors, take note.
The Motley Fool March 17, 2006 Rick Aristotle Munarriz	Lock, Stock, and Cracker Barrel Cracker Barrel looks to unload its casual steakhouse and repurchase a ton of stock. Investors, take note.
The Motley Fool March 17, 2006 Seth Jayson	The GM Lesson Investors, the revised loss isn't the problem here -- it's the inability to know what this mess is worth. There are more reliable ways to make money. Take note.
The Motley Fool March 17, 2006 Rich Smith	Foolish Forecast: Shuffling Into the Weekend Investors, let's hope the analysts know what they're talking about here. Because over the past 18 months, Shuffle Master has been on a bit of a losing streak, margins-wise.
The Motley Fool March 17, 2006 Jeremy MacNealy	Have Faith in True Religion Denim company True Religion has been a tremendous growth story, and by all indications, it's just getting started. Investors, take note.
The Motley Fool March 17, 2006 Rick Aristotle Munarriz	WorldSpace Oddity The international satellite radio provider is growing -- but not fast enough. As much as India's economy is likely to grow, WorldSpace's bottom-heavy balance sheet doesn't grant it the luxury of patience.
The Motley Fool March 17, 2006 Stephen D. Simpson	Petco and the Battle for Fido Is there room for two strong pet-supply emporiums? Investors, take note.
The Motley Fool March 17, 2006 Rich Duprey	Eisai's Dementia Problems Clinical trials for expanded use of the Japanese pharma's top-selling drug reveal higher incidences of death. Aricept is already approved for vascular dementia in several countries, but it would seem that FDA approval for use here won't be coming any time soon. Investors, take note.
<Older 13091-13100 Newer> Return to current articles.